Editorial: potassium-competitive acid blockers for acid-related diseases-tegoprazan, a new kid on the block-Reference-Cited by-同舟云学术

Editorial: potassium-competitive acid blockers for acid-related diseases-tegoprazan, a new kid on the block

Published:2019-10 Issue:8 Volume:50 Page:960-962
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Scarpignato Carmelo¹²³^ORCID,Hunt Richard H.⁴

Affiliation:

1. Faculty of Medical Sciences; LUdeS Lugano Campus; Lugano Switzerland

2. United Campus of Malta; Msida Malta

3. Faculty of Medicine; Chinese University of Hong Kong; Ma Liu Shui Hong Kong

4. Division of Gastroenterology and Farncombe Family Digestive Health Research Institute, Department of Medicine; McMaster University; Hamilton ON Canada

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15480/fullpdf

Reference10 articles.

1. No acid, no ulcer: Dragutin (Carl) Schwarz (1868-1917), the man ahead of his time;Fatović-Ferenčić;Dig Dis,2011

2. Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005;Hunt;Aliment Pharmacol Ther,2005

3. Potent acid suppression with PPIs and P-CABs: what's new?;Hunt;Curr Treat Options Gastroenterol,2018

4. The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease;Scarpignato;Curr Opin Gastroenterol,2019

5. Clinical trial: inhibitory effect of revaprazan on gastric acid secretion in healthy male subjects;Kim;J Gastroenterol Hepatol,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase III Head-to-Head Study to Compare the Efficacy and Safety of Fexuprazan and Esomeprazole in Treating Patients with Erosive Esophagitis;Journal of Clinical Medicine;2024-05-31

2. History and Pharmacological Mechanism of Gastric Acid-suppressive Drugs;The Korean Journal of Helicobacter and Upper Gastrointestinal Research;2023-09-15

3. Competitive proton pump inhibitors - status and Prospects of use;Experimental and Clinical Gastroenterology;2023-07-26

4. Pharmacokinetic Interactions Between Tegoprazan and Naproxen, Aceclofenac, and Celecoxib in Healthy Korean Male Subjects;Clinical Therapeutics;2022-07

5. Night‐time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole;British Journal of Clinical Pharmacology;2022-02-23